Results
|
|
61.
|
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer. [electronic resource] by
- Treilleux, I
- Arnedos, M
- Cropet, C
- Wang, Q
- Ferrero, J-M
- Abadie-Lacourtoisie, S
- Levy, C
- Legouffe, E
- Lortholary, A
- Pujade-Lauraine, E
- Bourcier, A-V
- Eymard, J-C
- Spaeth, D
- Bachelot, T
Producer: 20150824
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
62.
|
Prognostic factors in 1,038 women with metastatic breast cancer. [electronic resource] by
- Largillier, R
- Ferrero, J-M
- Doyen, J
- Barriere, J
- Namer, M
- Mari, V
- Courdi, A
- Hannoun-Levi, J M
- Ettore, F
- Birtwisle-Peyrottes, I
- Balu-Maestro, C
- Marcy, P Y
- Raoust, I
- Lallement, M
- Chamorey, E
Producer: 20090217
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
|
63.
|
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study. [electronic resource] by
- Swain, S M
- Ewer, M S
- Viale, G
- Delaloge, S
- Ferrero, J-M
- Verrill, M
- Colomer, R
- Vieira, C
- Werner, T L
- Douthwaite, H
- Bradley, D
- Waldron-Lynch, M
- Kiermaier, A
- Eng-Wong, J
- Dang, C
Producer: 20190408
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
64.
|
Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial. [electronic resource] by
- Pierga, J-Y
- Bidard, F-C
- Cropet, C
- Tresca, P
- Dalenc, F
- Romieu, G
- Campone, M
- Mahier Aït-Oukhatar, C
- Le Rhun, E
- Gonçalves, A
- Leheurteur, M
- Dômont, J
- Gutierrez, M
- Curé, H
- Ferrero, J-M
- Labbe-Devilliers, C
- Bachelot, T
Producer: 20140707
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
|
65.
|
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). [electronic resource] by
- Viens, P
- Palangié, T
- Janvier, M
- Fabbro, M
- Roché, H
- Delozier, T
- Labat, J P
- Linassier, C
- Audhuy, B
- Feuilhade, F
- Costa, B
- Delva, R
- Cure, H
- Rousseau, F
- Guillot, A
- Mousseau, M
- Ferrero, J M
- Bardou, V J
- Jacquemier, J
- Pouillart, P
Producer: 19991014
In:
British journal of cancer vol. 81
Availability: No items available.
|
|
|
66.
|
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. [electronic resource] by
- Ploquin, A
- Pistilli, B
- Tresch, E
- Frenel, J S
- Lerebours, F
- Lesur, A
- Loustalot, C
- Bachelot, T
- Provansal, M
- Ferrero, J M
- Coussy, F
- Debled, M
- Kerbrat, P
- Vinceneux, A
- Allouache, D
- Morvan, F
- Dalenc, F
- Guiu, S
- Rouzier, R
- Vanlemmens, L
Producer: 20190111
In:
European journal of cancer (Oxford, England : 1990) vol. 95
Availability: No items available.
|
|
|
67.
|
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer. [electronic resource] by
- Gonçalves, A
- Pierga, J-Y
- Ferrero, J-M
- Mouret-Reynier, M-A
- Bachelot, T
- Delva, R
- Fabbro, M
- Lerebours, F
- Lotz, J-P
- Linassier, C
- Dohollou, N
- Eymard, J-C
- Leduc, B
- Lemonnier, J
- Martin, A-L
- Boher, J-M
- Viens, P
- Roché, H
Producer: 20160421
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
68.
|
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group. [electronic resource] by
- Ray-Coquard, I
- Weber, B
- Cretin, J
- Haddad-Guichard, Z
- Lévy, E
- Hardy-Bessard, A C
- Gouttebel, M C
- Geay, J-F
- Aleba, A
- Orfeuvre, H
- Agostini, C
- Provencal, J
- Ferrero, J M
- Fric, D
- Dohollou, N
- Paraiso, D
- Salvat, J
- Pujade-Lauraine, E
Producer: 20090323
In:
British journal of cancer vol. 100
Availability: No items available.
|
|
|
69.
|
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. [electronic resource] by
- Jacquet, E
- Lardy-Cléaud, A
- Pistilli, B
- Franck, S
- Cottu, P
- Delaloge, S
- Debled, M
- Vanlemmens, L
- Leheurteur, M
- Guizard, A V
- Laborde, L
- Uwer, L
- Jacot, W
- Berchery, D
- Desmoulins, I
- Ferrero, J M
- Perrocheau, G
- Courtinard, C
- Brain, E
- Chabaud, S
- Robain, M
- Bachelot, T
Producer: 20190111
In:
European journal of cancer (Oxford, England : 1990) vol. 95
Availability: No items available.
|
|
|
70.
|
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. [electronic resource] by
- Cottu, P
- D'Hondt, V
- Dureau, S
- Lerebours, F
- Desmoulins, I
- Heudel, P-E
- Duhoux, F P
- Levy, C
- Mouret-Reynier, M-A
- Dalenc, F
- Frenel, J-S
- Jouannaud, C
- Venat-Bouvet, L
- Nguyen, S
- Ferrero, J-M
- Canon, J-L
- Grenier, J
- Callens, C
- Gentien, D
- Lemonnier, J
- Vincent-Salomon, A
- Delaloge, S
Producer: 20191125
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
71.
|
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study. [electronic resource] by
- Delaloge, S
- Pérol, D
- Courtinard, C
- Brain, E
- Asselain, B
- Bachelot, T
- Debled, M
- Dieras, V
- Campone, M
- Levy, C
- Jacot, W
- Lorgis, V
- Veyret, C
- Dalenc, F
- Ferrero, J M
- Uwer, L
- Kerbrat, P
- Goncalves, A
- Mouret-Reynier, M A
- Petit, T
- Jouannaud, C
- Vanlemmens, L
- Chenuc, G
- Guesmia, T
- Robain, M
- Cailliot, C
Producer: 20180102
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
72.
|
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. [electronic resource] by
- Pierga, J-Y
- Bidard, F-C
- Autret, A
- Petit, T
- Andre, F
- Dalenc, F
- Levy, C
- Ferrero, J-M
- Romieu, G
- Bonneterre, J
- Lerebours, F
- Bachelot, T
- Kerbrat, P
- Campone, M
- Eymard, J-C
- Mouret-Reynier, M-A
- Gligorov, J
- Hardy-Bessard, A-C
- Lortholary, A
- Soulie, P
- Boher, J-M
- Proudhon, C
- Charafe-Jaufret, E
- Lemonnier, J
- Bertucci, F
- Viens, P
Producer: 20180501
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|